North America Heparin Market – Industry Trends and Forecast to 2026

  • Pharmaceutical
  • Published Report
  • Jul 2019
  • North America
  • 350 Pages
  • No of Tables: 141
  • No of Figures: 33

North America Heparin Market By Product Type (Unfractionated Heparin, Low Molecular Weight Heparin (LMWH), Ultra-Low Molecular Weight Heparin (ULMWH), Mode of Administration (Oral Administration, Parenteral Administration), Source (Bovine, Porcine), Ingredients(Sodium, Calcium, Others), Availability (Raw, Processed), Treatment (Deep Vein Thrombosis, Pulmonary Embolism, Arterial Thromboembolism, Others), Application (Pre-Surgical Procedures, Post-Surgical Procedures, Kidney Dialysis, Diagnostic Tests, Others), Therapeutics (Cardiovascular, Respiratory, Oncology, Nephrology, CNS, Others), Strength (10 Unit, 100 Unit, 1000 Unit, 5000 Unit, 10000 Unit, 25000 Unit, Others), Type (Generics, Brands), Container (Bottles, Bags, Vials, Others), Packaging (Glass, Plastic), End User (Hospitals, Clinics, Homecare, Ambulatory Surgical Centres, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy & Drug Store, Online Pharmacy, Others), Country (U.S., Canada, Mexico) – Industry Trends and Forecast to 2026

Heparin is medication is used to prevent and treat blood clots. It is used to treat blood clotting disorders. It is also used to prevent blood clots after surgery, during blood transfusions, dialysis, and blood samples. It helps in smooth blood flowing by releasing anti-clotting protein. It is known as an anticoagulant. It is also used in diagnose and treatment of disseminated intravascular coagulation, deep vein thrombosis, pulmonary embolism, and arterial thromboembolism. It cannot dissolve blood clots but only prevent the clots from becoming larger and causing more serious problems. Heparin is an animal-derived product, derived from mucosal tissues of slaughtered meat animals.

Heparin is used for Diagnosis of heart attacks and unstable angina, Inhibition of cancer, metabolic disorders, and hepatitis, as an anti-inflammatory drug in injuries as Anti-Coagulants in blood sampling.

North America heparin market is projected to register a substantial CAGR in the forecast period 2019 to 2026.

Segmentation: North America Heparin Market

North America Heparin market is segmented into fourteen notable segments which are product type, mode of administration, source, ingredients, availability, treatment, application, therapeutics, strength, brands, Type, container, packaging, end user, distribution channel.

  • On the basis of product type, the market is segmented into unfractionated heparin, low molecular weight heparin (LMWH) and ultra-low molecular weight heparin (ULMWH)
  • On the basis of mode of administration, the market is segmented into oral administration and parenteral administration
  • On the basis of source, the market is segmented into bovine and porcine
  • On the basis of ingredients, the market is segmented into sodium and calcium and others
  • On the basis of availability, the market is segmented into raw, and processed
  • On the basis of treatment, the market is segmented into deep vein thrombosis, pulmonary embolism, arterial thromboembolism and others
  • On the basis of application, the market is segmented into pre-surgical procedures, post-surgical procedures, kidney dialysis, diagnostic tests and others
  • On the basis of therapeutics, the market is segmented into cardiovascular, respiratory, oncology, nephrology, CNS and others
  • On the basis of strength, the market is segmented into 10 unit, 100 unit, 1000 unit, 5000 unit, 10000 unit, 25000 unit and others
  • On the basis of type, the market is segmented into generics and brands
  • On the basis of container, the market is segmented into bottles, bags, vials and others
  • On the basis of packaging, the market is segmented into glass and plastic
  • On the basis of end user, the market is segmented into hospitals, clinics, homecare, ambulatory surgical centers and others
  • On the basis of distribution channel, the market is segmented into hospital pharmacy, retail pharmacy & drug store, online pharmacy and others

Competitive Analysis: North America Heparin Market

Some of the major players operating in this market are Sanofi, Pfizer Inc, F. Hoffmann-La Roche Ltd , Mylan N.V., Aspen Holdings, changzhaou Qianhong Bio-pharma Co., ltd., Eisai Co., Ltd., Fresenius Kabi AG, Hebei Changshan Biochemical Pharmaceutical Co. Ltd., Hikma Pharmaceuticals PLC, LEO Pharma A/S, Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd., Novartis AG, OPOCRIN S.P.A, SARIA SE & Co. KG, Shanghai Fosun Pharmaceutical (Group) Co., Ltd, Shenzhen Hepalink Pharmaceutical Group Co., Ltd., Shenzhen Techdow Pharmaceutical Co., Ltd, Teva Pharmaceutical Industries Ltd., Yino Pharma Limited, and among others.

Recent Developments:

  • In August 2018, Fresenius Kabi launched four new Heparin Sodium in freeflex containers. It is advance IV-container technology. The major advantage of this product launch is to expand the portfolio of convenient, ready-to-administer medicines in non-DEHP bags as well as in prefilled syringes.
  • In December 2017, Mylan N.V. received FDA approval for its Abbreviated New Drug Applications (ANDAs) for Heparin Sodium Injection USP, 1,000 USP/mL, 5,000 USP/mL, 10,000 USP/mL, and 20,000 USP/mL, all of which are packaged in multi-dose vials. Adding this product in their product line will generate revenue for the company and help the company in expanding its product portfolio in the market.
  • In February 2015, Pfizer Inc. spent USD 17,000 million to acquire Hospira which deals with biosimilar—generic versions of biologic drugs, made from living cells biologic drugs. The deal includes the commercial rights for anticoagulant heparin sodium which will help the company in generating the revenue and growth in the heparin market.

Research Methodology: North America Heparin Market

Primary Respondents:

Key Opinion Leaders (KOL’s): Manufacturers, Researchers, Distributors and Pharmacologist, Industrialists.

Industry Participants: CEO’s, V.P.’s, Marketing/Product Managers, Market Intelligence Managers and, National Sales Managers.


SKU-

TABLE 1 NORTH AMERICA HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 2 NORTH AMERICA UNFRACTIONATED HEPARIN IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 3 NORTH AMERICA LOW MOLECULAR WEIGHT HEPARIN (LMWH) IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 4 NORTH AMERICA LOW MOLECULAR WEIGHT HEPARIN (LMWH) IN HEPARIN MARKET, BY PRODUCT TYPE, 2016-2026 (USD MILLION)

TABLE 5 NORTH AMERICA ULTRA LOW MOLECULAR WEIGHT HEPARIN (ULMWH) IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 6 NORTH AMERICA ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) IN HEPARIN MARKET, BY TYPE, 2016-2026 (USD MILLION)

TABLE 7 NORTH AMERICA HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 8 NORTH AMERICA ORAL IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 9 NORTH AMERICA PARENTERAL ADMINISTRATION IN HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2016-2026 (USD MILLION)

TABLE 10 NORTH AMERICA PARENTRAL IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 11 NORTH AMERICA HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 12 NORTH AMERICA BOVINE IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 13 NORTH AMERICA PORCINE IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 14 NORTH AMERICA HEPARIN MARKET, BY INGREDIENTS, 2016-2026 (USD MILLION)

TABLE 15 NORTH AMERICA SODIUM IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 16 NORTH AMERICA CALCIUM IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 17 NORTH AMERICA OTHERS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 18 NORTH AMERICA HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 19 NORTH AMERICA RAW IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 20 TABLE1 NORTH AMERICA PROCESSED IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 21 NORTH AMERICA HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 22 NORTH AMERICA DEEP VEIN THROMBOSIS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 23 NORTH AMERICA PULMONARY EMBOLISM IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 24 NORTH AMERICA ARTERIAL THROMBOEMBOLISM IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 25 NORTH AMERICA OTHERS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 26 NORTH AMERICA HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 27 NORTH AMERICA PRE-SURGICAL PROCEDURES IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 28 NORTH AMERICA POST-SURGICAL PROCEDURES IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 29 NORTH AMERICA KIDNEY DIALYSIS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 30 NORTH AMERICA DIAGNOSTIC TEST IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 31 NORTH AMERICA OTHERS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 32 NORTH AMERICA HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 33 NORTH AMERICA CARDIOVASCULAR IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 34 NORTH AMERICA RESPIRATORY IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 35 NORTH AMERICA ONCOLOGY IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 36 NORTH AMERICA NEPHROLOGY IN HEPARIN MARKET,BY REGION, 2017-2026 (USD MILLION)

TABLE 37 NORTH AMERICA CNS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 38 NORTH AMERICA OTHERS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 39 NORTH AMERICA HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 40 NORTH AMERICA 10 UNITS IN HEPARIN MARKET,BY REGION, 2017-2026 (USD MILLION)

TABLE 41 NORTH AMERICA 100 UNIT IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 42 NORTH AMERICA 1000 UNITS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 43 NORTH AMERICA 5000 UNITS IN HEPARIN MARKET,BY REGION, 2017-2026 (USD MILLION)

TABLE 44 NORTH AMERICA 10000 UNITS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 45 NORTH AMERICA 25000 UNITS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 46 NORTH AMERICA OTHERS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 47 NORTH AMERICA GENERICS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 48 NORTH AMERICA HEPARIN MARKET, BY BRANDED, 2017-2026 (USD MILLION)

TABLE 49 NORTH AMERICA BRANDEDS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 50 NORTH AMERICA HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 51 NORTH AMERICA BOTTLES IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 52 NORTH AMERICA BAGS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 53 NORTH AMERICA VIALS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 55 NORTH AMERICA HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 56 NORTH AMERICA GLASS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 57 NORTH AMERICA PLASTIC IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 58 NORTH AMERICA HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 59 NORTH AMERICA HOSPITALS IN HEPARIN MARKET,BY REGION, 2017-2026 (USD MILLION)

TABLE 60 NORTH AMERICA CLINICS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 61 NORTH AMERICA HOMECARE IN HEPARIN MARKET,BY REGION, 2017-2026 (USD MILLION)

TABLE 62 NORTH AMERICA AMBULATORY SURGICAL CENTERS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 63 NORTH AMERICA OTHERS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 64 NORTH AMERICA HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 65 NORTH AMERICA HOSPITAL PHARMACY IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 66 NORTH AMERICA RETAIL PHARMACY & DRUG STORE IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 67 NORTH AMERICA ONLINE PHARMACY IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 68 NORTH AMERICA OTHERS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 69 NORTH AMERICA HEPARIN MARKET, BY COUNTRY, 2017-2026 (USD MILLION)

TABLE 70 NORTH AMERICA HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 71 NORTH AMERICA LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 72 NORTH AMERICA ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 73 NORTH AMERICA HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 74 NORTH AMERICA PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 75 NORTH AMERICA HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 76 NORTH AMERICA HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 77 NORTH AMERICA HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 78 NORTH AMERICA HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 79 NORTH AMERICA HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 80 NORTH AMERICA HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 81 NORTH AMERICA HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 82 NORTH AMERICA HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 83 NORTH AMERICA BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 84 NORTH AMERICA HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 85 NORTH AMERICA HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 86 NORTH AMERICA HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 87 NORTH AMERICA HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 88 U.S. HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 89 U.S. LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 90 U.S. ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 91 U.S. HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 92 U.S. PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 93 U.S. HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 94 U.S. HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 95 U.S. HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 96 U.S. HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 97 U.S. HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 98 U.S. HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 99 U.S. HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 100 U.S. HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 101 U.S. BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 102 U.S. HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 103 U.S. HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 104 U.S. HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 105 U.S. HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 106 CANADA HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 107 CANADA LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 108 CANADA ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 109 CANADA HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 110 CANADA PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 111 CANADA HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 112 CANADA HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 113 CANADA HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 114 CANADA HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 115 CANADA HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 116 CANADA HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 117 CANADA HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 118 CANADA HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 119 CANADA BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 120 CANADA HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 121 CANADA HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 122 CANADA HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 123 CANADA HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 124 MEXICO HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 125 MEXICO LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 126 MEXICO ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 127 MEXICO HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 128 MEXICO PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 129 MEXICO HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 130 MEXICO HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 131 MEXICO HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 132 MEXICO HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 133 MEXICO HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 134 MEXICO HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 135 MEXICO HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 136 MEXICO HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 137 MEXICO BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 138 MEXICO HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 139 MEXICO HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 140 MEXICO HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 141 MEXICO HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
BUY NOW ADD TO CART
Why Choose Us
REQUEST FOR SAMPLE